The role of thrombin in coagulation

JanGertNel 1,144 views 44 slides May 24, 2019
Slide 1
Slide 1 of 44
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44

About This Presentation

A birds eye view of an amazing molecule's role in several biological processes.


Slide Content

The role of Thrombin in haemostasis

Alexander Schmidt Described that the conversion of fibrinogen to fibrin is the result of an enzymatic process Named the hypothetical enzyme “thrombin” and it’s precursor “pre-thrombin”

In this presentation: Haemostasis –a brief overview Basic biochemistry The moves The dance

A brief overview of a complex system Essential haematology 5 th edition

Prothrombin Zymogen Inactive precursor enzyme 72 kDa single chain protein mainly produced in liver Serine protease Enzyme that depends on the presence of serine in it’s active center to hidrolyse peptide bonds Active site Carboxyl terminal Catalytic triad of serine, aspartic acid and histidine Vitamin K dependant t1/2 = 60 hours

Thrombin: 36 kDa molecule formed when prothrombin is cleaved by prothrombinase complex Sodium activated allosteric enzyme Inactivated by antithrombin and removed from the circulation by the liver

Thrombin: Structure Two polypeptide chains B-chain Active site Functional epitopes Sodium binds between the two chains Exosite I Exosite II Di Cera E. Thrombin as proccoagulant and anticoagulant.J Thromb Hemost 2007;5(Suppl. 1):196-202

Thrombin structure: Exosite I Integrity required by fibrinogen for docking onto the thrombin surface Contains: Numerous hydrophobic patches and charged residues on it’s surface Provides electrostatic steering to fibrinogen on it’s approach to the active site Fast rate of complex formation Provides the locale for docking to TM Di Cera E. Thrombin as proccoagulant and anticoagulant.J Thromb Hemost 2007;5(Suppl. 1):196-202

Thrombin structure: Exosite II Locale for interaction with polyanionic ligands Heparin Glucoseaminoglycans Di Cera E. Thrombin as proccoagulant and anticoagulant.J Thromb Hemost 2007;5(Suppl. 1):196-202

Essential haematology 5 th edition

Thrombin generation in vivo Network of amplification and negative feedback loops Localised and limited production Two waves of different magnitude Initiation phase Picomolar [] Preparation for second larger burst Amplification phase Micromolar [] Three procoagulant enzyme complexes: Consisting of: Protease, cofactor, PL and calcium Tissue factor complex, tenase , prothrombinase

Coagulation in vivo: Initiation phase Initial generation of thrombin TF factor bearing cells: Mononuclear cells Endothelial cells Stromal fibroblasts TF bearing cell surface: Only displays TF once activated Factors V, IX, X activated Small amount of thrombin produced

Coagulation in vivo: Amplification phase The first thrombin generated prepares for the thrombin burst that occurs on the surface of activated platelets

Coagulation in vivo: Propagation phase Propagation occurs on the surface of activated platelets, leading to the formation of large amounts of thrombin

Clot stabilization Fibrinogen Produced in the liver T1/2 of 4/7 Dimer consisting of three paired chains Fibrin monomer Formed after T cleaves fibtinopeptides from a and b chains Fibrin polymer Self assembly of monomers, end to end association of D domains Crosslinked fibrin Covalent bonds between chains Resistant to fibrinolysis Essential haematology 5 th edition

Clot stabilization Factor XIII Converts loose fibrin into a firm organized structure Transglutaminase Catalyses crosslinking through the formation of gluatmine -lysine covalent bonds between chains Ciculates as a hetrotetramer Activation Requires T and Ca ++ Two steps Limited proteolysis by T Dissociation of B subunits in the presence of Ca ++

Cells responding to thrombin stimulation Cellular effects mediated by protease activated receptors (PARs) PAR G-protein Highly expressed in platelets Also found EC, Monocytes , fibroblasts, T-lymphocytes, neurons, smooth muscle cells 1,3,4 activated by thrombin

Cells responding to thrombin stimulation PAR Carry their own ligands Ligands remain tethered to receptor after the cleaving of the receptor by thrombin Activation irreversible Duration of activity limited by rapid internalization of receptor Used once and then discarded

Essential haematology 5 th edition

Thrombin -effects on endothelial cells Signals EC and vascular smooth muscle cells to: Control vascular resistance Amplifies the inflammatory response by modulating transendothelial movement of neutrophils and plasma proteins

Essential haematology 5 th edition

Thrombin -effects on platelets Most potent platelet activator Shape change Aggregation b.m.o integrin binding to vWF and fibrinogen Induces synthesis and sectretion of: ADP 5-HT Thromboxane A2 EDPGF

Thrombin -effects on platelets PAR-1 Increased intracellular [Ca 2+ ] Upregulation GP IIb/ IIIa Mobilization of P- selectin and CD40-L to platelet surface increased binding of platelets to fibrinogen and an increase in cross linking PAR-4 Modulate and stabilize interplatelet binding

Thrombin and physiological limitation of blood coagulation Important that the effect of thrombin is limited to the site of injury By –direct inhibition indirect inhibition

Thrombin and physiological limitation of blood coagulation: Tissue factor pathway inhibitor Synthesized in endothelial cells Present: plasma platelets Accumulates at the site of injury –platelet activation Inhibits: Xa VIIa via formation of the quaternary complex TF

Thrombin and physiological limitation of blood coagulation Antithrombin Serpin Direct inhibitor of thrombin Inactivates serine proteases by combining with them by peptide bonding –forming high mw stable complexes Stable complexes rapidly removed from the circulation in the liver

Thrombin and physiological limitation of blood coagulation Antithrombin Neutralization of thrombin enhanced when T is bound to TM Antithrombin activity enhanced by binding to heparans

Thrombin and physiological limitation of blood coagulation The protein C pathway

Thrombin and physiological limitation of blood coagulation The Protein C Anticoagulation Pathway Complex interaction of multiple proteins on cell surfaces Major players Thrombin, thrombomodulin, proteins C & S

Thrombin and physiological limitation of blood coagulation Thrombomodulin Presented by EC Binds to Thrombin at exosite I Inhibits fibrinogen binding at exosite I Slows fibrin generation Decreases the level of free thrombin available for procoagulant activity. Contributes to the activation of Prot C Promotes stereo chemical association between the active site of thrombin with the cleavage site on proteinC

Thrombin and physiological limitation of blood coagulation APC Inactivates Factor Va and VIIIa Promotes fibrinolysis by complexing and inactivating PAI-1

Thrombin and fibrinolysis

Fibrinolysis Thrombin Inhibits fibrinolysis by activating TAFI via the T, TM complex TAFI acts by removing the terminal lysine residues of fibrin that normally facilitate the binding action of Plasmin and tPA Promotes fibrinolysis via the protein C pathway

Just a reminder

Dancing Na + activated allosteric enzyme Slow Fast

Dancing: The role of Na + Activity Physiological [Na + ] not sufficient for saturation System optimally poised for allosteric regulation Na + binding required for Optimal cleaving of fibrinogen Activation of: Factor 5, 8, 9 necessary for the explosive generation of thrombin

Dancing: The role of Na + Promotes the prothrombotic and signalling functions by enhacing cleavage of PAR1, PAR3 and PAR4 destabilized Na + binding anticoagulant effect

Sources Essential Haematology Mechanisms in haematology Di Cera E. Thrombin as procoacgulant and anticoagulant. Journal of Thrombosis and Haemostasis , 5(Suppl. 1):196-202 Di Cera E. Thrombin; Molec Aspects of Medicine 2008;29(4):203-254 Huntingdon. Slow thrombin is zymogen -like. Journal of Thrombosis and haemostasis 2009; 7(S1STATE): 159-164